The antibody produces a strong postive labeling of LHRH / GnRH at dilution of 1/2,000 - 1,4,000 using biotin-streptavidin/HRP in rat hypothalamus (median eminence). Optimal dilution will vary depending upon fixation, labeling technique and/or detection system; therefore, a dilution series is recommended. The above image is of LHRH (GnRH) terminals in rat median eminence, ryostat sections, ABC / DAB detection.Staining is completely eliminated by pretreatment of the diluted antibody with 5 µg of LHRH per mL of diluted antiserum.
Photo Description: IHC image of staining for LNRH/GnRH in the rat median eminence. The tissue was fixed with 4% formaldehyde in phosphate buffer, before being removed and prepared for vibratome sectioning. Floating sections were incubated at RT in 10% goat serum in PBS, before standard IHC procedure. Primary antibody was incubated at 1:4000 for 48 hours, goat anti-rabbit secondary was subsequently added for 1 hour after washing with PBS. Light microscopy staining was achieved with standard biotin-streptavidin/HRP procedure and DAB chromogen.
Host: Rabbit
Quantity / Volume: 100 µL
State: Lyophilized Whole Serum
Reacts With: Bat, Carp, Catfish, Chick, Chicken, Clarias Batrachus (Catfish), Fish, Frog, Frog (Green Treefrog), Gerbil, Guinea Pig, Guinea Pig, Hagfish, Hamster, Human, Lizard, Mole Rat, Monkey, Mouse, Mudpuppy (Necturus Maculosus), Octopus, Pig, Rat, Salamander, Snail, Snail (Bulla Gouldiana), Squid, Trout
Availability: In Stock
Alternate Names: Gonadotropin-Releasing Hormone; Gonadorelin; Luliberin I; Gonadoliberin I; progonadoliberin-1; GRH, anti-LHRH
Gene Symbol: GNRH1 RRID: AB_572248Database Links:
Entrez Gene:103295055 Bat Entrez Gene: 770134 Chick Entrez Gene: 100135026 Frog Entrez Gene: 100135531 Guinea Pig Entrez Gene: 100774729 Hamster Entrez Gene: 2796 Human Entrez Gene: 101705387 Mole Rat Entrez Gene: 613033 Monkey Entrez Gene: 14714 Mouse Entrez Gene: 397516 Pig Entrez Gene: 25194 Rat Entrez Gene: 100135917 Trout
阿尔茨海默氏症协会称,阿尔茨海默氏症的研究抗体在帮助科学家找到解决这种疾病和其他痴呆症的方法方面发挥着重要作用,这些疾病和痴呆症影响了全世界4700万人和530万美国人,到2050年,这一数字有望增加两倍。随着婴儿潮一代的年龄增长,预计将有2800万人患上这种疾病,其费用将升至美国医疗保险总支出的近四分之一。
自从Aloysius Alzheimer博士于1906年首次描述这种疾病以来,科学家们在了解这种疾病如何影响大脑方面取得了显着进步。十多年后,理解和治疗的突破为阿尔茨海默氏病患者带来了希望。
这些ImmunoStar抗体已在阿尔茨海默氏症的研究中得到证明。用关键字“阿尔茨海默氏病” 搜索我们出版物的数据库,以查找数百种引用这些抗体的出版物。有关神经科学家的意见,请参阅我们的客户推荐书,以赞扬他们从ImmunoStar获得的结果和服务。我们的抗体稳定,高滴度,并且批次间一致,可确保成功染色并获得极佳的价值。